Vitamin D3 induces tolerance in human dendritic cells by activation of intracellular metabolic pathways

Cell Reports

Volumn 10, Issue 5, 2015, Pages 711-725

  Ferreira, GabrielaBomfim ^a   Vanherwegen, An Sofie ^a   Eelen, Guy ^a,b   Gutiérrez, Ana Carolina Fierro ^a   VanLommel, Leentje ^a   Marchal, Kathleen ^a,c   Verlinden, Lieve ^a   Verstuyf, Annemieke ^a   Nogueira, Tatiane ^d   Georgiadou, Maria ^a,b   Schuit, Frans ^a   Eizirik, Décio L ^d   Gysemans, Conny ^a   Carmeliet, Peter ^a,b   Overbergh, Lut ^a   Mathieu, Chantal ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; GLUCOSE; MAMMALIAN TARGET OF RAPAMYCIN; OXYGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

AEROBIC METABOLISM; ARTICLE; CELL FUNCTION; CELL METABOLISM; CITRIC ACID CYCLE; CONTROLLED STUDY; DENDRITIC CELL; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; METABOLIC ACTIVATION; MICROARRAY ANALYSIS; MONOCYTE; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION;

EID: 84923383047     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.01.013     Document Type: Article

References (38)

1. Belladonna M.L., Volpi C., Bianchi R., Vacca C., Orabona C., Pallotta M.T., Boon L., Gizzi S., Fioretti M.C., Grohmann U., Puccetti P. Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. J.Immunol. 2008, 181:5194-5198.
2. Bocelli-Tyndall C., Zajac P., Di Maggio N., Trella E., Benvenuto F., Iezzi G., Scherberich A., Barbero A., Schaeren S., Pistoia V., et al. Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells. Arthritis Rheum. 2010, 62:3815-3825.
3. Clambey E.T., McNamee E.N., Westrich J.A., Glover L.E., Campbell E.L., Jedlicka P., de Zoeten E.F., Cambier J.C., Stenmark K.R., Colgan S.P., Eltzschig H.K. Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc. Natl. Acad. Sci. USA 2012, 109:E2784-E2793.
4. Colston K.W., Hansen C.M. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr. Relat. Cancer 2002, 9:45-59.
5. Dang C.V. Links between metabolism and cancer. Genes Dev. 2012, 26:877-890.
6. Dang E.V., Barbi J., Yang H.Y., Jinasena D., Yu H., Zheng Y., Bordman Z., Fu J., Kim Y., Yen H.R., et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 2011, 146:772-784.
7. Delmastro-Greenwood M.M., Piganelli J.D. Changing the energy of an immune response. Am. J. Clin. Exp. Immunol. 2013, 2:30-54.
8. Everts B., Amiel E., van der Windt G.J., Freitas T.C., Chott R., Yarasheski K.E., Pearce E.L., Pearce E.J. Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood 2012, 120:1422-1431.
9. Everts B., Amiel E., Huang S.C., Smith A.M., Chang C.H., Lam W.Y., Redmann V., Freitas T.C., Blagih J., van der Windt G.J., et al. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKε supports the anabolic demands of dendritic cell activation. Nat. Immunol. 2014, 15:323-332.
10. Ferreira G.B., van Etten E., Lage K., Hansen D.A., Moreau Y., Workman C.T., Waer M., Verstuyf A., Waelkens E., Overbergh L., Mathieu C. Proteome analysis demonstrates profound alterations in human dendritic cell nature by TX527, an analogue of vitamin D. Proteomics 2009, 9:3752-3764.
11. Ferreira G.B., Kleijwegt F.S., Waelkens E., Lage K., Nikolic T., Hansen D.A., Workman C.T., Roep B.O., Overbergh L., Mathieu C. Differential protein pathways in 1,25-dihydroxyvitamin d(3) and dexamethasone modulated tolerogenic human dendritic cells. J.Proteome Res. 2012, 11:941-971.
12. Ferreira G.B., Gysemans C.A., Demengeot J., da Cunha J.P., Vanherwegen A.S., Overbergh L., Van Belle T.L., Pauwels F., Verstuyf A., Korf H., Mathieu C. 1,25-Dihydroxyvitamin D3 Promotes Tolerogenic Dendritic Cells with Functional Migratory Properties in NOD Mice. J Immunol 2014.
13. Frauwirth K.A., Thompson C.B. Regulation of T lymphocyte metabolism. J.Immunol. 2004, 172:4661-4665.
14. Heikkinen S., Väisänen S., Pehkonen P., Seuter S., Benes V., Carlberg C. Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res. 2011, 39:9181-9193.
15. Hmama Z., Nandan D., Sly L., Knutson K.L., Herrera-Velit P., Reiner N.E. 1alpha,25-dihydroxyvitamin D(3)-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex. J.Exp. Med. 1999, 190:1583-1594.
16. Jones R.G., Thompson C.B. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev. 2009, 23:537-548.
17. Kleijwegt F.S., Laban S., Duinkerken G., Joosten A.M., Koeleman B.P., Nikolic T., Roep B.O. Transfer of regulatory properties from tolerogenic to proinflammatory dendritic cells via induced autoreactive regulatory Tcells. J.Immunol. 2011, 187:6357-6364.
18. Krauss S., Brand M.D., Buttgereit F. Signaling takes a breath-new quantitative perspectives on bioenergetics and signal transduction. Immunity 2001, 15:497-502.
19. Krawczyk C.M., Holowka T., Sun J., Blagih J., Amiel E., DeBerardinis R.J., Cross J.R., Jung E., Thompson C.B., Jones R.G., Pearce E.J. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 2010, 115:4742-4749.
20. Locasale J.W., Cantley L.C. Genetic selection for enhanced serine metabolism in cancer development. Cell Cycle 2011, 10:3812-3813.
21. Michalek R.D., Gerriets V.A., Jacobs S.R., Macintyre A.N., MacIver N.J., Mason E.F., Sullivan S.A., Nichols A.G., Rathmell J.C. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ Tcell subsets. J.Immunol. 2011, 186:3299-3303.
22. Pearce E.L., Pearce E.J. Metabolic pathways in immune cell activation and quiescence. Immunity 2013, 38:633-643.
23. Pearce E.L., Poffenberger M.C., Chang C.H., Jones R.G. Fueling immunity: insights into metabolism and lymphocyte function. Science 2013, 342:1242454.
24. Rohan J.N., Weigel N.L. 1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells. Endocrinology 2009, 150:2046-2054.
25. Salehi-Tabar R., Nguyen-Yamamoto L., Tavera-Mendoza L.E., Quail T., Dimitrov V., An B.S., Glass L., Goltzman D., White J.H. Vitamin D receptor as a master regulator of the c-MYC/MXD1 network. Proc. Natl. Acad. Sci. USA 2012, 109:18827-18832.
26. Sena L.A., Li S., Jairaman A., Prakriya M., Ezponda T., Hildeman D.A., Wang C.R., Schumacker P.T., Licht J.D., Perlman H., et al. Mitochondria are required for antigen-specific Tcell activation through reactive oxygen species signaling. Immunity 2013, 38:225-236.
27. Shaw R.J., Cantley L.C. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006, 441:424-430.
28. Shi L.Z., Wang R., Huang G., Vogel P., Neale G., Green D.R., Chi H. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J.Exp. Med. 2011, 208:1367-1376.
29. Széles L., Keresztes G., Töröcsik D., Balajthy Z., Krenács L., Póliska S., Steinmeyer A., Zuegel U., Pruenster M., Rot A., Nagy L. 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J.Immunol. 2009, 182:2074-2083.
30. Unger W.W., Laban S., Kleijwegt F.S., van der Slik A.R., Roep B.O. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur. J. Immunol. 2009, 39:3147-3159.
31. van der Windt G.J., Everts B., Chang C.H., Curtis J.D., Freitas T.C., Amiel E., Pearce E.J., Pearce E.L. Mitochondrial respiratory capacity is a critical regulator of CD8+ Tcell memory development. Immunity 2012, 36:68-78.
32. van Halteren A.G., van Etten E., de Jong E.C., Bouillon R., Roep B.O., Mathieu C. Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3). Diabetes 2002, 51:2119-2125.
33. van Halteren A.G., Tysma O.M., van Etten E., Mathieu C., Roep B.O. 1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive Tcells via the selective induction of apoptosis. J.Autoimmun. 2004, 23:233-239.
34. Vats D., Mukundan L., Odegaard J.I., Zhang L., Smith K.L., Morel C.R., Wagner R.A., Greaves D.R., Murray P.J., Chawla A. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab. 2006, 4:13-24.
35. Wang R., Green D.R. Metabolic checkpoints in activated Tcells. Nat. Immunol. 2012, 13:907-915.
36. Wang H., Brown J., Gu Z., Garcia C.A., Liang R., Alard P., Beurel E., Jope R.S., Greenway T., Martin M. Convergence of the mammalian target of rapamycin complex 1- and glycogen synthase kinase 3-β-signaling pathways regulates the innate inflammatory response. J.Immunol. 2011, 186:5217-5226.
37. Williams A., Henao-Mejia J., Harman C.C., Flavell R.A. miR-181 and metabolic regulation in the immune system. Cold Spring Harb. Symp. Quant. Biol. 2013, 78:223-230.
38. Zeng H., Yang K., Cloer C., Neale G., Vogel P., Chi H. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature 2013, 499:485-490.